NCT01142609

Brief Summary

This research is being done to compare the effectiveness of standard on-site, in-person counseling with Internet web-based videoconferencing (e-therapy) in drug-dependent patients in opioid-agonist treatment programs. The study is looking to see if there are any differences in satisfaction or in treatment outcome if counseling sessions are given by e-therapy compared to standard, in-person counseling given in the clinic. The e-therapy happens in real time- it works very much like standard therapy in the clinic except that the patient is in his or her own home (or other convenient location outside the clinic) and talks to and sees the therapist through an Internet connection on the computer (the therapist will usually be at the clinic).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 10, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 11, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
Last Updated

April 4, 2013

Status Verified

April 1, 2013

Enrollment Period

2.7 years

First QC Date

June 10, 2010

Last Update Submit

April 2, 2013

Conditions

Keywords

Web based videoconferencingmethadonesubstance abuse counseling

Outcome Measures

Primary Outcomes (3)

  • Counseling efficacy

    Attendance to individual counseling sessions, both online and on-site will be tracked weekly for the duration of the study.

    Weekly for 12 weeks

  • Reinforcement value (eGetgoing)

    Subjects will complete monthly surveys to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).

    Monthly for 3 months

  • Reinforcement value (on-site)

    Subjects will complete a survey to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).

    Baseline

Secondary Outcomes (3)

  • Program Satisfaction

    Baseline and monthly for 3 months

  • Treatment cost

    Baseline and Month 3

  • Therapeutic relationship

    Baseline and monthly for 3 months

Study Arms (2)

Internet (eGetgoing)

EXPERIMENTAL

Subjects will assigned to use an accredited web-based platform (eGetgoingTM, CRC Health Group, Inc.) to deliver routine substance abuse counseling.

Behavioral: eGet

Routine on-site

NO INTERVENTION

Subjects will attend routine face-to-face individual counseling sessions.

Interventions

eGetBEHAVIORAL

eGet individual counseling sessions from home will be scheduled weekly for 12 weeks.

Internet (eGetgoing)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Access to a computer with Internet capability
  • Full adherence to their routine counseling schedule over the previous 30-days
  • Negative urine specimens over the previous 30-days
  • Patient at ATS for 90 days

You may not qualify if:

  • No access to a computer with Internet capability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Addiction Treatment Services

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Van King, M.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 10, 2010

First Posted

June 11, 2010

Study Start

December 1, 2009

Primary Completion

August 1, 2012

Study Completion

August 1, 2012

Last Updated

April 4, 2013

Record last verified: 2013-04

Locations